NEW YORK (Reuters) - Just weeks after prosecutors accused Forest Laboratories Inc of illegally marketing its anti-depressants Celexa and Lexapro to children and paying pediatricians kickbacks, U.S.
Forest Pharmaceuticals Inc. and Forest Laboratories Inc. are facing multiple proposed class actions in which the plaintiffs allege antidepressants Celexa and Lexapro were unlawfully marketed to treat ...
THURSDAY, Aug. 15 (HealthScoutNews) -- The U.S. Food and Drug Administration (FDA) today approved the drug Lexapro (escitalopram) for the treatment for major depression. Lexapro resulted from a ...
WASHINGTON, Feb 25 (Reuters) - The United States accused Forest Laboratories Inc of inappropriately marketing the drugs Celexa and Lexapro for children and paying kickbacks like spa visits to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results